Pupillometer Market Size, Share, Opportunities, And Trends By Mobility (Table-top, Hand-held), By Type (Video, Digital), By Application (Ophthalmology, Neurology, Oncology, Others), And By Geography - Forecasts From 2023 To 2028

The pupillometer market is estimated to grow at a CAGR of 5.28% during the forecast period.

Pupillometry, which measures pupil dilation to understand a variety of underlying diseases, is widely being utilized. Changes in brain activity have been found to have a direct influence on pupil dilation by several imaging modalities, including MRI and CT. Therefore, monitoring pupil dilation aids in a deeper understanding of cognitive processes.

On the other hand, people with autism spectrum disorder, Parkinson's illness, sadness, and anxiety have also displayed aberrant pupillometry responses to stimuli. Therefore, pupillometry aids in comprehending both a person's normal eye functionality and the brain activity that is affected by an illness.

Increase in patients suffering from neurological disorders 

Globally the burden of non-communicable neurological illnesses is rising, mostly as a result of the aging population. The main causes of neurological illnesses include epilepsy, headache conditions, and stroke. Since pupillometers are used to measure the curvature of the eye to identify neurological problems, this causes a rise in demand for these instruments further fueling the pupillometer industry. Thus, it is anticipated that the pupillometer market would develop over the projected period as the number of persons with neurological illnesses rises.

Increasing government initiative

Numerous governmental and commercial organizations are working to increase understanding of neurological illnesses and access to healthcare. For instance, a non-profit organization (NPO) devoted to the advancement of neuromodulation science is the International Neuromodulation Society (INS). Through conferences, peer-reviewed publications, illuminating material, and websites, it also disseminates information and encourages neuromodulation. Therefore, the pupillometer market's expansion over the projection period is driven by an increase in awareness campaigns and advancements in healthcare access.

Hand-held pupillometers are expected to grow significantly 

During the projected period, the hand-held pupillometers are anticipated to develop at the quickest rate. Using a portable pupillometer, the user may quickly and precisely capture a picture of the pupil that can be used to diagnose several neurological conditions, including Alzheimer's disease.

Additionally, the hand-held pupillometer is becoming more and more developed and popular due to its convenience in movement. One of the top manufacturers of handheld pupillometers for both critical care and practical research is NeurOptics. Furthermore, businesses like Adaptica have developed a hybrid hand-held gadget called 2WIN that has pupillometry as a function. 

Increasing usage of video pupillometer

A video pupillometer makes it possible to record the whole process of pupil dilation, which aids in understanding variations and their causes. Using cutting-edge technology, NeurOptics, a business that deals with the science of pupillometry, enables doctors to deliver improved patient care. The business has developed a variety of video pupillometers for both critical care and practical research. NeurOptics created the video pupillometer NPi-200 for use in critical care. This item has an infrared camera, a CPU, very accurate optics, and an LED light source. The product's video function aids in documenting how the pupil size and its response vary over time.

Increasing technological advancements 

Pupilometers have been significantly improved in terms of accuracy, usefulness, and usability because of technological improvements. Traditional pupillometers measured pupillary responses using visible light. However, infrared pupillometry is already the norm in contemporary gadgets. When capturing pupillary data, infrared light is used, which gives greater precision and dependability, especially under diverse lighting situations.

High-resolution cameras with cutting-edge imaging capabilities are now included in pupillometers to record accurate and detailed photographs of the pupil. Additionally, to improve the diagnostic capabilities of pupillometers, Al algorithms are being created and implemented into them. 

The North American pupillometer market is anticipated to grow significantly.

North America held the majority of the pupillometer market share due to the rising frequency of neurological illnesses and vision-related issues, Additionally, it is anticipated that the acceptance and installation of a pupillometer across a variety of settings in the U.S. would fuel pupillometer market share.

Major industry companies like NeurOptics, which has its headquarters in the United States and is developing a sophisticated pupillometer for improved diagnosis there. To broaden the use of its product for other medical problems, the business is also investigating the use of pupillometer in several critical care domains.

Asia Pacific region is predicted to show growth potential

During the projected period, the Asia Pacific region is anticipated to show major growth potential.  The region's expanding access to pupillometers via a variety of online marketplaces and providers is anticipated to support the pupillometer market expansion.

Furthermore, major manufacturers in the international pupillometer industry as NeurOptics, Johnson & Johnson Vision, and Konan Medical are offering a pupillometer through their subsidiaries. Through its distributors in India, Japan, and South Korea—Hansraj Nayyar Medical India, IMI Co., and Neuroplus—NeurOptics offers its pupillometer. Additionally, the presence of international players like NIDEK has improved the region's access to and availability of pupillometers.

Strategies Used by Key Players

To raise knowledge of pupillometry and the range of their pupillometers, pupillometer market participants are taking part in trade events, exhibits, and conferences. These industry players are also working on portable devices to address the mobility issue and improve the device's usability in a variety of contexts. Additionally, businesses have developed cutting-edge software that can be put on mobile devices to finish the pupillometry process remotely.

Market Key Developments

• In December 2022, The updated 2021 European Resuscitation Council (ERC) and European Society of Intensive Care Medicine (ESICM) Guidelines for post-resuscitation care include NeurOptics' Neurological Pupil IndexTM (NPi®) and automated pupillometry as an objective measurement supporting neurological prognosis in patients after cardiac arrest.
• In May 2022, In 15 nations, NeurOptics Inc. introduced the NPi-300 pupillometer. The United Kingdom, France, Italy, Ireland, Australia, and New Zealand are a few of the nations where the pupillometer has been introduced.

Segmentation:

• By Mobility
  • Table-top
  • Hand-held
• By Type
  • Video
  • Digital
• By Application
  • Ophthalmology
  • Neurology
  • Oncology
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Indonesia
    • Thailand
    • Others